CVE-2023-38952Insecure access control in ZKTeco BioTime through 9.0.1 allows authenticated attackers to escalate their privileges due to the fact that…
- 7.5HighCVSS base score
- 2.7%Exploitation in 30 daysEPSS · top 14% of all CVEs
- NoKnown exploitednot in CISA's KEV catalog
- 1Public exploitsMetasploit, Nuclei and Exploit-DB
Description
Insecure access control in ZKTeco BioTime through 9.0.1 allows authenticated attackers to escalate their privileges due to the fact that session ids are not validated for the type of user accessing the application by default. Privilege restrictions between non-admin and admin users are not enforced and any authenticated user can leverage admin functions without restriction by making direct requests to administrative endpoints.
Public exploit
An exploit or proof of concept is public: anyone can try it against an unpatched system. The public collections list a Nuclei template for it. A reference of the record is tagged as an exploit. CISA's SSVC rates its exploitation: a proof of concept is public.
Show the exploits2
Nuclei templates1 template
- ZKTeco BioTime <= 9.0.1 - Privilege Escalation (Nuclei template) (opens in a new tab)
http/cves/2023/CVE-2023-38952.yamlSeverity high
References tagged exploit1 reference
Modules, templates and exploits as listed by the Metasploit Framework (BSD-3-Clause), ProjectDiscovery's Nuclei templates (MIT) and the Exploit Database (GPLv2), read once a day. Where the data comes from
Timeline
ID reserved
By mitre
- 9 days later
· 9 days later
Published
- 3 years later
· 3 years later
Record updated
Changes after publication (a new score, a public exploit, EPSS crossing 1, 10 or 50 %, leaving KEV) are kept since November 2026; earlier ones are not known.
Scores
| Scored by | CVSS | Score | Vector |
|---|---|---|---|
| CISA-ADPADP (enrichment) | 3.1 | High7.5 | CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N |
| NVDNVD · Modified | 3.1 | High7.5 | CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N |
- EPSS (exploitation in 30 days)
- 2.7% · top 14% of all CVEs (14 Nov 2026)
- CISA SSVC
- Exploitation: poc · Automatable: yes · Technical impact: partial
The list uses the assigner's score when there is one, then CISA's, then NVD's: High 7.5.
Affected products
n/a
- affected n/a
References
References4
- https://claroty.com/team82/disclosure-dashboard/cve-2023-38952 (opens in a new tab)x_transferred
- https://github.com/omair2084/biotime-rce-8.5.5/blob/main/biotime_enum.py (opens in a new tab)
- https://krashconsulting.com/fury-of-fingers-biotime-rce/ (opens in a new tab)
- https://sploitus.com/exploit?id=PACKETSTORM:177859 (opens in a new tab)exploit
Sources
The same CVE in the primary databases and aggregators, to check against.
- CVE.org record (opens in a new tab)
- CVE List JSON (GitHub) (opens in a new tab)
- NVD (opens in a new tab)
- FIRST EPSS (opens in a new tab)
- EUVD EUVD-2023-42712 (opens in a new tab)
- OSV.dev (opens in a new tab)
- GitHub Advisories (opens in a new tab)
- CIRCL Vulnerability-Lookup (opens in a new tab)
Badge for a README or a ticket
[](https://cveledger.app/cve/CVE-2023-38952)Record last updated .